Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
A glioma is a type of tumor that starts in the glial cells of the brain or the spine. Gliomas comprise about 30 percent of all brain tumors and central nervous system tumours, and 80 percent of all malignant brain tumours.
Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has very poor prognosis for survival. Initial signs and symptoms of glioblastoma are nonspecific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.
The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.
Denise Sheer was appointed professor of human genetics at The Institute of Cell and Molecular Science at Queen Mary, University of London in November 2006. Her fields of expertise include cell and molecular biology; cancer genetics and epigenetics; and molecular pathology of paediatric brain tumours.
Paul Christopher Blomfield is a British politician who has served as the Member of Parliament (MP) for Sheffield Central since 2010. A member of the Labour Party, he was a Shadow Minister for Exiting the European Union from 2016 to 2020 and Shadow Minister for Brexit and European Union Negotiations from 2020 to 2021.
The Save A Brain Foundation was a 501(c)(3) non-profit organization with the goals of raising awareness of glioblastoma multiforme (GBM), the most common type of primary brain tumor, as well as raising money in hopes of finding a cure for this terminal disease. To date, the foundation has raised tens of thousands of dollars for brain cancer research.
Diffuse midline glioma, H3 K27-altered (DMG) is a fatal tumour that arises in midline structures of the brain, most commonly the brainstem, thalamus and spinal cord. When located in the pons it is also known as diffuse intrinsic pontine glioma (DIPG).
The Edinburgh Cancer Research Centre (ECRC), also known as the Cancer Research UK Edinburgh Centre and the University of Edinburgh Cancer Research Centre, is a center for basic, translational and clinical cancer research located in Edinburgh, Scotland. ECRC constitutes a part of the Institute of Genetics & Molecular Medicine (IGMM) and is positioned in direct proximity of the Western General Hospital, where most of its clinical activities take place.
The Robert Connor Dawes Foundation is an Australian not-for-profit organisation that facilitates funding in brain research, care and development in Australia and the United States. The foundation was created in June 2013 by Liz Dawes and Scott Dawes in memory of their son Robert Connor Dawes who died from a brain tumour in April 2013 at 18 years of age. As of July 31, 2015, they changed their name from Robert Connor Dawes Fund to Robert Connor Dawes Foundation.
The Queen Elizabeth Hospital Charity was created mainly to support medical and health research, and to fund and encourage excellence in healthcare for patients and their caregivers, wholly or mainly through the services provided by University Hospital Birmingham NHS Foundation Trust. It raises money for campaigns that are over and above what the NHS can provide. QEH Charity was formed in 2001, however, there has been an official charity associated with the Queen Elizabeth Hospital since the creation of the NHS in 1948. QEH became independent in April 2016.
The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Sheila K. Singh MD, PhD, FRCSC is a chief pediatric neurosurgeon at McMaster Children's Hospital in Ontario, Canada. She is also Professor of Surgery and Biochemistry, the Division Head of Neurosurgery at Hamilton Health Sciences, the Research Director for McMaster's Division of Neurosurgery, and a scientist/principal investigator appointed to the Stem Cell and Cancer Research Institute at McMaster University.
Professor Richard James Gilbertson is a paediatric oncology clinician scientist and a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, and Director of the CRUK Cambridge Major Centre and the Children's Brain Tumour Centre of Excellence.
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.
Brain Tumor Awareness Month or Brain Cancer Awareness Month is observed each March in the UK, and every May in Canada, Australia and the United States.
Rolando Fausto Del Maestro is an Italian-born Canadian neurosurgeon, the William Feindel Professor Emeritus in neuro-oncology and director of the Neurosurgical Simulation Research Center at the Montreal Neurological Institute and Hospital, where he has been involved in simulating real brain surgery by creating virtual setting scenarios, founded upon the principles of flight simulation.
